Tamoxifen Citrate Tablet
NDC Package 63187-976-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Tamoxifen Citrate tablets is tamoxifen is used to treat breast cancer. This formulation utilizes a tablet delivery system. Marketed by Proficient Rx Lp, this product is identified by NDC 63187-976 and is authorized under FDA application ANDA070929.

Identification & Billing

NDC Package Code
63187-976-30
Package Description
30 TABLET in 1 BOTTLE, PLASTIC
Product Code
63187-976
11-Digit Billing Format
63187097630
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tamoxifen Citrate
Non-Proprietary Name
Tamoxifen Citrate
Substance Name
Tamoxifen Citrate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TAMOXIFEN CITRATE 20 mg/1
Pharmacologic Class
Usage Information
Tamoxifen is used to treat breast cancer. It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue.

Regulatory & Marketing

Labeler Name
Proficient Rx Lp
Product Type
Human Prescription Drug
FDA Application #
ANDA070929
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-15-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63187-976). Click a package code to view its specific billing and regulatory data.

63187-976-60
60 TABLET in 1 BOTTLE, PLASTIC
63187-976-90
90 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63187-976-30 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Tamoxifen Citrate, a human prescription drug labeled by Proficient Rx Lp. This tablet is formulated for oral use and contains tamoxifen citrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proficient Rx Lp on August 15, 2011. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Tamoxifen is used to treat breast cancer. It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue.

How is this Proficient Rx Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63187097630. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63187-976-30
11-Digit CMS (5-4-2)
63187-0976-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.